GcMAF is an unlicensed blood product that claims to treat a number of conditions, including cancer and autism. The BBC sent an undercover reporter to buy the product from a firm in Guernsey called First Immune.
Second generation GcMAF is tested for macrophage phagocytic activity and has been shown to exhibit anti-angiogenic and antitumor effects. It is typically administered via intramuscular and subcutaneous injection, twice a week. For more information, check out Gcmaf capsules!
What is Gcmaf?
GcMAF is a glycoprotein that naturally occurs in the body and activates phagocytic macrophages. It has also been shown to generate superoxide free radicals and has antiangiogenic effects. GcMAF is available in the form of injections and capsules, and can be used to treat a wide range of conditions, including cancer, multiple sclerosis, autism, chronic fatigue syndrome, Lyme disease, and liver cirrhosis.
Our second-generation GcMAF is manufactured in our sterile Saisei Mirai cell processing center under aseptic conditions from healthy human serum that has been carefully screened and sterile filtered to ensure safety. Please see our GcMAF Tests page for more information.
After 3 months of treatment he was able to walk with assistance, his tremor of the limbs and head subsided, and his speech became clearer. He could even go up and down the stairs. He had a significant improvement on his liver fibrosis compared to before GcMAF treatment (15.3 kPa versus 7.8 kPa). He was given High-Dose GcMAF 0.5 ml three times weekly and daily Oral Colostrum MAF.
How is Gcmaf made?
GcMAF is a precursor protein called Gc protein that is converted to the hormone-like compound GCSF, which then activates macrophages (a type of white blood cell that engulfs and digests cellular debris and pathogens). It is extracted from bovine colostrum that is carefully screened and sterile filtered to ensure its safety.
The researchers who retracted their studies didn’t use the proper tests to measure nagalase levels, and they also didn’t test whether GcMAF actually activated macrophages in patients’ bodies. Instead, they measured levels of a substance in patients’ blood that is produced when cancer cells break down.
MHRA is investigating a company in Guernsey that is selling unlicensed GcMAF, which is being used to treat conditions including cancer and autism. One woman told the BBC that she spent her retirement savings buying it and her tumours have not regressed. The National Autistic Society is concerned that people are being given false hope and says people should talk to their GP if they have concerns.
What are the side effects of Gcmaf?
GcMAF is an immunostimulant that increases macrophage activity and enhances the body’s ability to eradicate cancer cells, viruses, bacteria, and other pathogens. It is a natural substance produced by the body and is derived from bovine colostrum, which contains antibodies and other growth factors. It has been used by some patients with various illnesses and is marketed to parents of autistic children.
A case study showed that second-generation GcMAF and oral colostrum MAF helped to significantly improve the motor disability of a patient with MS. After six weeks of treatment, the patient could walk with assistance and climb stairs, whereas before treatment he had been wheelchair-bound for four years.
Activation of macrophages by GcMAF can be combined with most conventional therapies, particularly those that don’t have any side effects on the immune system (such as hormone therapy, Herceptin treatments, and irradiation). One course of High-Dose GcMAF is usually 48 doses over 6 months (2 times weekly administration). Long term maintenance doses can be administered in the form of injections or orally to keep macrophages activated.
Where can I buy Gcmaf?
Although GcMAF hasn’t been proven to treat cancer, some companies sell it online. They often post on social media to avoid government regulation. They may also claim that GcMAF can help people with autism. Guernsey authorities have warned that it is illegal to market and sell unlicensed medicines in the bailiwick, external link. The BBC’s undercover investigation found that a company called First Immune advertised GcMAF on a website and offered to ship it to the UK from the island. The MHRA has warned that these products could pose a serious risk to health. People taking these products should seek medical advice as soon as possible.